Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
AC Immune Receives Second Milestone Payment Following Progress in Phase 2b…
AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer's DiseasePrescreening rate of Phase 2b ReTain trial triggers clinical development milestone payment in SeptemberPotentially registrational trial is targeting enrollment of approximately 500 participants with pre-symptomatic ADFDA Fast Track designation granted in July for ACI-35.030 (now “JNJ-2056”) for AD Lausanne, Switzerland, September 17, 2024– AC...
Nasdaq GlobeNewswire
17/09/2024
BioNTech to Host AI Day as an Edition of its Innovation Series on October 1…
MAINZ, Germany, September 17, 2024 (GLOBE NEWSWIRE)-- BioNTech SE (Nasdaq: BNTX, “BioNTech”), alongside its artificial intelligence (“AI”) company InstaDeep Ltd. (“InstaDeep”), will host an AI Day, an edition of BioNTech's “Innovation Series”, at 09:00 a.m. EDT (3:00 p.m. CEST) on Tuesday, October 1 st, 2024 in London, United Kingdom. The event will provide an overview of BioNTech's and InstaDeep's AI strategy and capabilities, and the application of AI in BioNTech's pipeline and...
Nasdaq GlobeNewswire
17/09/2024
Cevira (APL-1702): Photocure Partner Asieris Unveils Efficacy Data of…
Read Asieris' full media release here: https://asieris.com/asieris-unveils-results-for-the-first-time-at-2024-pdtpd-conference-the-efficacy-data-of-non-surgical-treatment-of-cervical-hsil-with-apl-1702-in-reducing-the-histological-grade-of-cervical-preca/ Read Asieris' full media release here:...
PR Newswire
17/09/2024
Ureteral Access Sheath Market to Reach $2.2 Billion, Globally, by 2033 at 5.5%…
Prime determinants of growth Prime determinants of growth The global ureteral access sheath market is witnessing notable growth due to surge in cases of kidney stones. Kidney stones, or renal calculi, are crystalline mineral deposits that form within the kidneys or urinary tract, posing significant health risks and causing debilitating pain. This surge in prevalence is attributed to various factors, including dietary habits, sedentary lifestyles, dehydration, and metabolic disorders...
PR Newswire
17/09/2024
RESOURCE-SAVING INNOVATION: MAMMUT LOOPINSULATION
From concept to innovation From concept to innovation The development of Loopinsulation began after an analysis of Mammut's carbon footprint in 2018, which revealed that 13% of the company's CO 2emissions came from rope manufacturing. In response, Mammut conducted extensive research on repurposing...
PR Newswire
17/09/2024
Monument Therapeutics Announces Grant of UK Patent for Neuroinflammation…
"The granting of this patent represents a significant achievement in our research and development efforts," said Jenny Barnett, Chief Executive Officer of Monument Therapeutics. "MT1980's innovative approach to targeting neuroinflammation positions us at the cutting edge of therapeutic advancement in psychiatry and neurology. We believe this compound has the potential to address significant unmet medical needs and our team is excited to advance MT1980 through the next stages of…
PR Newswire
17/09/2024
Safe Life completes acquisition of Medisol in Europe
Medisol, headquartered in the Netherlands, is one of the premier European distributors of AEDs with substantial expertise in eCommerce and operations across 30 European countries. This acquisition strategically complements Safe Life's existing portfolio, positioning us to effectively serve markets throughout North America and all of Europe. Medisol, headquartered inthe Netherlands, is one of the premier European distributors of AEDs with substantial expertise in eCommerce and operations...
PR Newswire
17/09/2024
MinervaX and Wacker Biotech Announce Manufacturing Collaboration for…
MinervaX's lead vaccine candidate, is a novel protein-only vaccine, based on fusions of highly immunogenic and proactive protein domains from selected surface proteins of GBS. The company is strongly committed and dedicated to advancing its novel vaccine and has successfully completed two Phase II clinical trials of its maternal vaccine against GBS and is in preparation to commence Phase III clinical trials in this indication. Data from MinervaX's GBS vaccine is very positive, demonstrating an…
PR Newswire
17/09/2024
Pampers is partnering with Olly Murs to help make Scratchy Bottom in Dorset the…
Pampers Premium Protection New Baby nappies (sizes 0-3) and Pampers Premium Protection nappies (sizes 4-6) feature an innovative DermaComfort Layer that instantly pulls wetness and mess away from the skin and locks it securely inside the nappy, so babies' delicate skin remains dry and protected from irritants. The ultra-soft materials help the skin to breathe and provide comfort and the Stop & Protect pocket helps to prevent leaks from escaping at the back. The nappies have also approved by…
PR Newswire
17/09/2024
IMU Biosciences expands leadership team with appointment of industry experts Dr…
IMU Biosciences expands leadership team with appointment of industry experts Dr. John Baker as Chief Executive Officer and Dr. Jason Brown as Chief Business OfficerLondon, UK, 17 September 2024– IMU Biosciences (or “the Company”), a biotechnology company pioneering systems-level immune profiling with AI to drive breakthroughs in precision medicine, today announces an expansion of its leadership team to support the next phase of the Company's growth. Dr. John Baker has been appointed...
Nasdaq GlobeNewswire
17/09/2024
EssilorLuxottica and Meta Announce Long Term Partnership, Shaping the Future of…
EssilorLuxottica and Meta Announce Long Term Partnership, Shaping the Future of the Smart Eyewear CategoryBuilding on the success of Ray-Ban Meta glasses, the two pioneering companiesaim to write history of wearables together Paris, France (17 September 2024)– EssilorLuxottica announced today that it has extended its partnership with Meta Platforms by entering into a new long term agreement, under which the parties will collaborate into the next decade to develop...
Nasdaq GlobeNewswire
17/09/2024
Véronique Pomi-Schneiter stands down as BioSenic's Deputy CEO
PRIVILEGED INFORMATION Mont-Saint-Guibert, Belgium, September 17, 2024 7.00pm CEST –BioSenic(Euronext Brussels and Paris: BIOS), the clinical stage company specializing in serious autoimmune and inflammatory diseases, today announces that Véronique Pomi-Schneiter resignes for personal reasons as Deputy CEO of BioSenic. Véronique Pomi-Schneiter will fully assist in the transition process and continue to serve as non-executive member of the board of directors of BioSenic, as well as...
Nasdaq GlobeNewswire
17/09/2024
Gates Foundation Report Calls for Targeted Global Health Spending to Save…
The Goalkeepers report, "A Race to Nourish a Warming World," projects that without immediate global action, climate change will condemn an additional 40 million children to stunting and 28 million more to wasting between 2024 and 2050. Scaling up solutions now can avoid this outcome, while also building resilience to climate change and spurring much-needed economic growth. The Goalkeepers report, "A Race to Nourish a Warming World," projects that without immediate global…
PR Newswire
17/09/2024
Expanding the Bispecific Antibody Market from CAR-Ts to Drive Follicular…
For those in the early stages of the disease (Ann Arbor stages I or II), treatment may involve radiation therapy alone or in combination with chemotherapy. Patients with advanced follicular lymphoma are typically treated initially with a combination of chemotherapy and anti-CD20 antibodies, a method known as chemoimmunotherapy. The most commonly used antibodies are RITUXAN (rituximab) and GAZYVA (obinutuzumab), which specifically target tumor cells associated with follicular lymphoma. In older…
PR Newswire
16/09/2024
Galapagos receives transparency notification from EcoR1 Capital
Mechelen, Belgium; 16 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from EcoR1 Capital LLC.Pursuant to Belgian transparency legislation 1, Galapagos received a transparency notification on 13 September 2024 on behalf of Mr. Oleg Nodelman and EcoR1 Capital LLC, who notified that EcoR1 Capital LLC holds 6,713,553 of Galapagos' voting rights, consisting of 839,388 ordinary shares and 5,874,165 American...
Nasdaq GlobeNewswire
16/09/2024
Sanofi: Information concerning the total number of voting rights and shares -…
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of theCode de commerce(the French Commercial Code) and article 223-16 of theRèglement général de l'Autorité des Marchés Financiers(Regulation of the French stock market authority) Sanofi a Frenchsociété anonymewith a registered share capital of 2,537,214,304 € Registered office : 46, avenue de la Grande Armée - 75017 Paris - France Registered at the Paris...
Nasdaq GlobeNewswire
16/09/2024
Lab Automation Market to Reach $11.31 Billion by 2031, Driven by Rising…
Download FREE PDF Brochure Of Lab Automation Market - https://www.meticulousresearch.com/pressrelease/967/lab-automation-market-2031 Download FREE PDF Brochure Of Lab Automation Market - https://www.meticulousresearch.com/pressrelease/967/lab-automation-market-2031 Rising pharmaceutical and biotech R&D expenditures, the increasing demand for automated laboratories and instruments, the high prevalence of chronic and infectious diseases, and initiatives supporting life sciences...
PR Newswire
16/09/2024
WestGene Biopharma Presents Groundbreaking mRNA Vaccine Data at ESMO 2024
WGc-043, the world's first mRNA therapeutic vaccine targeting EBV-positive tumors to achieve IND approval in both China and the US, demonstrated exceptional safety, immunogenicity, and anti-tumor activity in the latest clinical trials. The vaccine is being developed specifically for adult patients with advanced EBV-positive solid tumours and refractory or relapsed EBV-positive lymphomas, diseases for which there are currently no effective, low-toxicity treatment options. WGc-043, the world's...
PR Newswire
16/09/2024
Immunovia presents data from model development study at 2024 AACR Advances in…
The conference is being hosted by the American Association for Cancer Research (AACR) in Boston, Massachusetts. This special conference brings together leading pancreatic cancer researchers, physicians, and patient advocates to share innovative approaches for diagnosing and treating pancreatic cancer. The conference is being hosted by the American Association for Cancer Research (AACR) inBoston, Massachusetts. This special conference brings together leading pancreatic cancer researchers,...
PR Newswire
16/09/2024
TraceLink Co-Founder and SVP of Supply Network Products Lucy Deus Named…
As global supply chains face increased complexity, challenges, and digitalization opportunities, Lucy Deus is driving transformational change at TraceLink for the benefit of its customers and patients globally. As a critical leadership voice, Deus has been instrumental in bringing the voice of the customer and supply chain experience to help shape its unique Opus platform as a critical supply chain digitalization capability. This collaboration has ensured that the platform is optimized to meet…
PR Newswire
16/09/2024
Epitomee Medical Announces FDA Clearance of its Capsule, Weight Management…
The Epitomee® Capsule represents an innovative prescription option in weight management solutions, offering a drug-free alternative that differs from injectable treatments. With FDA clearance extending to adults with a BMI starting at 25, Epitomee® Capsule is accessible to a broader range of patients looking for tolerable and easy to use weight management solutions. The Epitomee® device is encased in a standard size, self-administered ingestible capsule. Once the Epitomee® Capsule is swallowed…
PR Newswire
16/09/2024
Coloplast A/S - Trading in Coloplast shares by board members, executives or…
Please see enclosed pdf. Attachment 16092024_trading_in_shares_KV
Nasdaq GlobeNewswire
16/09/2024
Lipid Nanoparticles Market to Reach USD 350.5M by 2029 | MarketsandMarkets™
Browse in-depth TOC on "Lipid Nanoparticles Market" Browse in-depth TOC on "Lipid Nanoparticles Market" 398 - Tables53 - Figures316 - Pages Factors Influencing Market Trends The expansion of the lipid nanoparticles market is driven by increasing research and development efforts to create lipid nanoparticle-based drugs. However, stringent regulatory requirements may impede growth. Product Segment Insights The market is segmented by product into ionizable...
PR Newswire
16/09/2024
Non-Invasive Prenatal Testing Market is expected to generate a revenue of USD…
The report highlights key market drivers, including the growing demand for early fetal detection, advancements in next-generation sequencing (NGS), and the increased adoption of safer prenatal testing methods. It also addresses critical market restraints such as high costs, regulatory hurdles, and limited insurance coverage, providing a balanced view of current market dynamics. The report highlights key market drivers, including the growing demand for early fetal detection, advancements in...
PR Newswire
16/09/2024
Altri Comunicati